Early thrombolytic treatment reduces analgesic requirement patients myocardial infarction duration amount analgesics patients myocardial infarction intravenous recombinant tissue-type plasminogen activator rtPA placebo randomized double-blind trial Infusion rtPA mg /placebo onset symptoms requirement analgesics following Sixty-seven cent rtPA-treated patients analgesic treatment patients placebo group study period patients rtPA group equivalent mg median value intravenous morphine mg placebo group conclusion present study early thrombolysis intravenous rtPA amount duration analgesic treatment patients myocardial infarction 